Close

Nektar Therapeutics (NKTR) Sees Early Weakness

September 27, 2016 9:50 AM EDT Send to a Friend
Nektar Therapeutics (NASDAQ: NKTR) is under heavy pressure this morning. Shares are down 8.6% on volume that is running ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login